Diadema Partners LP Mannkind Corp Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Mannkind Corp stock. As of the latest transaction made, Diadema Partners LP holds 519,900 shares of MNKD stock, worth $2.01 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
519,900Holding current value
$2.01 Million% of portfolio
0.68%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MNKD
# of Institutions
275Shares Held
172MCall Options Held
1.37MPut Options Held
248K-
Black Rock Inc. New York, NY22.6MShares$87.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$67 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$36.6 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$33.9 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY7.79MShares$30.1 Million7.16% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $996M
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...